Key Takeaways
- In 2022, approximately 48.7 million people aged 12 or older in the United States had a past year substance use disorder (SUD), equating to 17.3% of this population.
- Globally, an estimated 296 million people used drugs in 2021, a 23% increase from 2010.
- In the US, past-month illicit drug use among people aged 12 or older reached 24.9% or 70.4 million individuals in 2021.
- Among US males aged 12+, past-year SUD rate was 22.5% in 2022 compared to 12.4% for females.
- US females had higher rates of prescription opioid misuse at 1.4% past month vs. 1.2% males in 2021.
- Non-Hispanic White adults had the highest past-year opioid misuse rate of 3.3% in 2021.
- Opioid overdose deaths caused 109,680 fatalities in the US in 2022.
- Fentanyl was involved in 68% of all US overdose deaths in 2021.
- Drug-induced deaths rose to 107,941 in the US in 2021, age-adjusted rate 32.4 per 100,000.
- US drug misuse cost $1.02 trillion in 2017, including $504B healthcare.
- Illicit drug use economic burden was $740 billion annually in US 2007, updated to $1T+.
- Opioid crisis cost US $1.02 trillion in 2020, with $504B lost productivity.
- Only 10.3% of US people with SUD received treatment in 2022.
- Medication-assisted treatment (MAT) with buprenorphine reaches only 23% of opioid use disorder patients.
- Relapse rates for drug addiction average 40-60% within first year post-treatment.
Drug addiction is a severe and widespread global crisis affecting tens of millions of people.
Demographic Statistics
Demographic Statistics Interpretation
Economic and Social Costs
Economic and Social Costs Interpretation
Health and Mortality Statistics
Health and Mortality Statistics Interpretation
Prevalence and Usage Statistics
Prevalence and Usage Statistics Interpretation
Treatment and Recovery Statistics
Treatment and Recovery Statistics Interpretation
Sources & References
- Reference 1SAMHSAsamhsa.govVisit source
- Reference 2UNODCunodc.orgVisit source
- Reference 3NIDAnida.nih.govVisit source
- Reference 4CDCcdc.govVisit source
- Reference 5DEAdea.govVisit source
- Reference 6EMCDDAemcdda.europa.euVisit source
- Reference 7WHOwho.intVisit source
- Reference 8NIAAAniaaa.nih.govVisit source
- Reference 9THELANCETthelancet.comVisit source
- Reference 10AIHWaihw.gov.auVisit source
- Reference 11CANADAcanada.caVisit source
- Reference 12VAva.govVisit source
- Reference 13THETREVORPROJECTthetrevorproject.orgVisit source
- Reference 14BOPbop.govVisit source
- Reference 15HUDUSERhuduser.govVisit source
- Reference 16NIMHnimh.nih.govVisit source
- Reference 17NCBIncbi.nlm.nih.govVisit source
- Reference 18NIAnia.nih.govVisit source
- Reference 19AHAJOURNALSahajournals.orgVisit source
- Reference 20DRUGABUSESTATISTICSdrugabusestatistics.orgVisit source
- Reference 21ASPEaspe.hhs.govVisit source
- Reference 22RANDrand.orgVisit source
- Reference 23CHILDWELFAREchildwelfare.govVisit source
- Reference 24NCJRSncjrs.govVisit source
- Reference 25NEJMnejm.orgVisit source






